medpagetoday.com
'A lot of areas in which we're going to see a lot of improvements,' says Michael E. Wechsler, MD
4 months ago
medpagetoday.com
Drug did not increase oxygen-free days versus placebo in randomized study
4 months ago
medpagetoday.com
Structured exercise improves fatigue and pain but requires long-term patient commitment
4 months ago
medpagetoday.com
Early data show promise with abemaciclib; other combinations advancing through dose finding
4 months ago
medpagetoday.com
Hormone receptor-positive patients with high TMB may fare well with immunotherapy
4 months ago
medpagetoday.com
Experts weigh the role of MRD in personalizing treatment but caution against premature changes
3 months ago
medpagetoday.com
Greater area deprivation linked to worse progression-free and overall survival
3 months ago
medpagetoday.com
3-year disease-free survival rate was 96% with blinatumomab versus 87.9% with chemo alone
3 months ago
medpagetoday.com
Study highlights missed opportunities for post-diagnosis interventions
3 months ago
medpagetoday.com
Hopes are that using natural killer cells with naxitamab and gemcitabine is a winning combo
3 months ago
medpagetoday.com
CDK4/6 inhibitor extended progression-free survival by nearly 15 months in phase III trial
3 months ago
Media DatabaseFind the right journalists
Online NewsroomShape your own narrative
Press Release CreatorCreate and send press releases
Media MonitoringTrack every single online mention
Media Pitching ToolContact recommendations & stats
PR ReportsShowcase the impact of your work
PR CRMManage contacts in easy way
AI PR SoftwareUse AI to save time on your workflow
Social Media ListeningGet a full overview of your brand's presence